Meluka Honey Appoints OpenDNA for Chinese Market Entry
Filed with ASX · · 2 pages · English
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- EVE to Acquire Remaining 50% of Meluka Health
- Response to ASX Appendix 4C Query
- Meluka Honey Secures Distribution for NSW & ACT
- Meluka Honey Combines Anti-Microbial & Anti-Oxidant Activity
- Appendix 4E and Full Year Statutory Accounts
Later from EVE Health
- Placement
- Meluka Honey Secures Distribution for Northern NSW & SEQ
- THC Global Agreement Update
- Response to Appendix 4C Query
- Pause in Trading
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health